Selective inhibition of cullin 3 neddylation through covalent targeting DCN1 protects mice from acetaminophen-induced liver toxicity
- Nat Commun. 2021 May 11;12(1):2621. doi: 10.1038/s41467-021-22924-4.
- 1. Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
- 2. Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA.
- 3. Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
- 4. Institute of Translational Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
- 5. Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. [email protected].
- 6. Department of Pharmacology, University of Michigan, Ann Arbor, MI, USA. [email protected].
- 7. Department of Medicinal Chemistry, University of Michigan, Ann Arbor, MI, USA. [email protected].
- # Contributed equally.
Cullin-RING E3 Ligases (CRLs) regulate the turnover of approximately 20% of mammalian cellular proteins. Neddylation of individual cullin proteins is essential for the activation of each CRL. We report herein the discovery of DI-1548 and DI-1859 as two potent, selective and covalent DCN1 inhibitors. These inhibitors selectively inhibit neddylation of cullin 3 in cells at low nanomolar concentrations and are 2-3 orders of magnitude more potent than our previously reported reversible DCN1 inhibitor. Mass spectrometric analysis and co-crystal structures reveal that these compounds employ a unique mechanism of covalent bond formation with DCN1. DI-1859 induces a robust increase of NRF2 protein, a CRL3 substrate, in mouse liver and effectively protects mice from acetaminophen-induced liver damage. Taken together, this study demonstrates the therapeutic potential of selective inhibition of cullin neddylation.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: E1/E2/E3 EnzymeResearch Areas: Cardiovascular Disease
-
Research Areas: Metabolic Disease